Supplemental Figure 3 from Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non–Small Cell Lung CancerCharu Aggarwal,Jeffrey C. Thompson,Austin L. Chien,Katie J. Quinn,Wei-Ting Hwang,Taylor A. Black,Stephanie S. Yee,Theresa E. Christensen,Michael J. LaRiviere,Benjamin A. Silva,Kimberly C. Banks,Rebecca J. Nagy,Elena Helman,Abigail T. Berman,Christine A. Ciunci,Aditi P. Singh,Jeffrey S. Wasser,Joshua M. Bauml,Corey J. Langer,Roger B. Cohen,Erica L. Carpentercrossref(2023)引用 0|浏览51暂无评分摘要pTMBand PD-L1 expression levels.更多查看译文AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要